CN1173357A - Pills for treating hepatitis B - Google Patents
Pills for treating hepatitis B Download PDFInfo
- Publication number
- CN1173357A CN1173357A CN 97110634 CN97110634A CN1173357A CN 1173357 A CN1173357 A CN 1173357A CN 97110634 CN97110634 CN 97110634 CN 97110634 A CN97110634 A CN 97110634A CN 1173357 A CN1173357 A CN 1173357A
- Authority
- CN
- China
- Prior art keywords
- radix
- liver
- herba
- fructus
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine in the form of pill for treating chronic infectious hepatitis B and the carrier of hepatitis B virus is prepared from 33 Chinese-medicinal materials such as astragalus root, white atractylodes rhizome, mulberry mistletoe, wolfberry fruit, poria, etc. and serves to increase immunity, improve microcirculation in liver, promote growth of liver cells, suppress the duplicate of HBVDNA, remove HBV, transforming HB5Ag, HBeAg and anti-HBC to negative and prevent the transform of HSs and HBe to positive
Description
Field of medicaments under the invention
Prescription: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Herba Taxilli, Fructus Lycii, Poria, Herba Hedyotidis Diffusae, Radix Salviae Miltiorrhizae, Sanguis Trionycis meat, Semen Juglandis, Fructus Jujubae, Alumen preparata, Herba Ephedrae, Ramulus Cinnamomi, Radix Paeoniae Rubra, Radix Bupleuri, Radix Scutellariae, Squama Manis, Radix Angelicae Sinensis, Semen Persicae, Bombyx Batryticatus, Radix Notoginseng, Cortex Magnoliae Officinalis, Fructus Aurantii, Fructus Amomi, Radix Aconiti Lateralis Preparata, Rhizoma Coptidis, Cortex Moutan, Radix Sophorae Tonkinensis, Radix Clerodenri Cyrtophylli, the Radix Paeoniae Alba, Radix Pseudostellariae, Radix Glycyrrhizae, Herba Artemisiae Scopariae are extracted through science and form through system.
Cure mainly: chronic persistent hepatitis B, hepatitis B virus (HBV) carrier.
Effect: inrigorating qi and promoting blood circulation, depressed liver-energy dispersing and QI regulating, spleen-invigorating and kidney-strengthening.Warming YANG ventilation detoxifcation dehumidifying.Suppress HDVDNA and duplicate, remove HBV, activated cell produces interferon, improves the little ring that starts of liver.Anti-hepatic fibrosis increases immunologic function, hepatic cell growth promotion.
Its invention is according to motherland's Chinese medicine principle, in conjunction with modern medicine, from clinical practice, recognize, chronic persistent hepatitis B, hepatitis B virus carriers, immunologic hypofunction, hepatic lesions, HBV are difficult to control, remove, with liver,spleen,kidney, the QI and blood functional disorder has special internal relation.The formation poison is invaded, weakened body resistance, the stagnation of QI, and the characteristics of blood resistance are taked the coupling of many methods, experience the clinical verification in year surplus in the of 30, inquires into the specific aim of medicine and answers, and develops pure Chinese medicinal preparation, pills for treating hepatitis B.Its side has inrigorating qi and promoting blood circulation, depressed liver-energy dispersing and QI regulating, spleen-invigorating and kidney-strengthening, warming YANG ventilation, detoxifcation dehumidifying, by drug influence, strengthens T cell, B cell function, promotes the thymocyte cell differentiation, and its cellular immune function is recovered.Activated cell produces interferon, improves liver microcirculation, strengthens phagocyte in the liver, removes endotoxin, hepatic cell growth promotion.Because body is under the hepatitis B virus effect, because of drug effect antibody strengthens, immune complex increases, to liver and the infringement of organ in addition thereof.The control immune complex has solved this contradiction.Promote hepatic tissue to recover, spleen-invigorating and kidney-strengthening, inrigorating qi and promoting blood circulation, warming YANG ventilation (activated cell produces interferon and improves immunologic function), depressed liver-energy dispersing and QI regulating is invigorated blood circulation, anti-hepatic fibrosis, improve liver microcirculation, the control immune complex, protect the liver) under the comprehensive function of detoxifcation dehumidifying (anti-HBV); Suppress HBVDNA and duplicate, remove HBV and make the cloudy commentaries on classics of the anti-HBC of HBsAg, HBeAg, anti-HBs, anti-HBe sun changes, and ALT is stable, liver retraction, hepatitis B transference cure.Reasonable recipe, it is fast that anti-HBV power improves immunologic function by force, and liver protective effect is good, and thorough treatment, difficult recurrence have science, originality, practicality, clinical expansion use value are arranged.
Claims (3)
1, system side: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Herba Taxilli, Fructus Lycii, Poria, Herba Hedyotidis Diffusae, Radix Salviae Miltiorrhizae, Sanguis Trionycis meat, Fructus Jujubae, Alumen preparata, Herba Ephedrae, helvolus, Ramulus Cinnamomi, Radix Paeoniae Rubra, Radix Bupleuri, Radix Scutellariae, Squama Manis, Radix Angelicae Sinensis, Semen Persicae, Bombyx Batryticatus, Radix Notoginseng, Cortex Magnoliae Officinalis, Fructus Aurantii, Fructus Amomi, Radix Aconiti Lateralis Preparata, Rhizoma Coptidis, Cortex Moutan, Radix Sophorae Tonkinensis, Radix Clerodenri Cyrtophylli, the Radix Paeoniae Alba, Radix Pseudostellariae, Radix Sophorae Flavescentis, its feature of Herba Artemisiae Scopariae suppresses HBVDNA and duplicates, it is strong to eliminate HBV power, it is remarkable to improve immunologic function, hepatic tissue recovers thoroughly, has inrigorating qi and promoting blood circulation, depressed liver-energy dispersing and QI regulating, spleen-invigorating and kidney-strengthening, the warming YANG ventilation, the detoxifcation dehumidifying, raise immunity, activated cell produces interferon, improve liver microcirculation, anti-hepatic fibrosis, the function that hepatocyte recovers.
2,1. described according to claim: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Herba Taxilli, Fructus Lycii, Herba Ephedrae, Ramulus Cinnamomi, Radix Rehmanniae Preparata, Radix Aconiti Lateralis Preparata, Radix Polygoni Ciliinerve, Fructus Jujubae spleen-invigorating and kidney-strengthening, inrigorating qi and promoting blood circulation, warming YANG ventilation, raise immunity, activated cell produce interferon, strengthen the T cell, the B cell recovers its immune cell function.Herba Hedyotidis Diffusae, Alumen preparata, Radix Clerodenri Cyrtophylli, Radix Sophorae Tonkinensis, Rhizoma Coptidis, Poria, the detoxifcation dehumidifying, anti-HBV, Sanguis Trionycis meat, Semen Juglandis, Radix Angelicae Sinensis, Semen Persicae, Radix Notoginseng, Radix Salviae Miltiorrhizae, the Radix Paeoniae Alba, Radix Glycyrrhizae, Bombyx Batryticatus, Squama Manis, Radix Bupleuri, Radix Scutellariae, Herba Artemisiae Scopariae, Cortex Moutan, Fructus Amomi, Radix Pseudostellariae, Cortex Magnoliae Officinalis, Fructus Aurantii, depressed liver-energy dispersing and QI regulating, improve liver microcirculation, anti-hepatic fibrosis, removing endotoxin suppress immune complex, hepatic cell growth promotion.Its feature suppresses HBVDNA and duplicates at liver, makes the liver retraction, and ALT is stable.
3,1. described according to claim: the anti-HBV power of its feature is strong, and it is fast to improve immunologic function, and liver protective effect height, thorough treatment, difficult recurrence are the specific medicaments of treatment chronic viral hepatitis B type hepatitis, HBVer and anti-recurrence.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97110634 CN1173357A (en) | 1997-04-27 | 1997-04-27 | Pills for treating hepatitis B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97110634 CN1173357A (en) | 1997-04-27 | 1997-04-27 | Pills for treating hepatitis B |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1173357A true CN1173357A (en) | 1998-02-18 |
Family
ID=5171501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 97110634 Pending CN1173357A (en) | 1997-04-27 | 1997-04-27 | Pills for treating hepatitis B |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1173357A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100333755C (en) * | 2005-10-31 | 2007-08-29 | 李顺定 | Nephrosis treating Chinese medicine boneyed bolus and its prepn process |
CN100441210C (en) * | 2003-12-30 | 2008-12-10 | 南京中医药大学 | Compound for mula preparation for treating chronic hepatitis B virus and its preparation method |
JP2009269902A (en) * | 2008-05-08 | 2009-11-19 | Ind Technol Res Inst | Chinese herbal medicine extract introducing production of interferon by immunocyte and activating toll-like receptor |
CN101385845B (en) * | 2007-09-11 | 2012-09-12 | 中山大学附属第三医院 | Traditional Chinese medicine preparation for treating hepatitis B |
CN104644867A (en) * | 2015-03-17 | 2015-05-27 | 邵国辉 | Combination medicine for improving anti-HBV curative effect of interferon and preparation method of combination medicine |
-
1997
- 1997-04-27 CN CN 97110634 patent/CN1173357A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100441210C (en) * | 2003-12-30 | 2008-12-10 | 南京中医药大学 | Compound for mula preparation for treating chronic hepatitis B virus and its preparation method |
CN100333755C (en) * | 2005-10-31 | 2007-08-29 | 李顺定 | Nephrosis treating Chinese medicine boneyed bolus and its prepn process |
CN101385845B (en) * | 2007-09-11 | 2012-09-12 | 中山大学附属第三医院 | Traditional Chinese medicine preparation for treating hepatitis B |
JP2009269902A (en) * | 2008-05-08 | 2009-11-19 | Ind Technol Res Inst | Chinese herbal medicine extract introducing production of interferon by immunocyte and activating toll-like receptor |
CN104644867A (en) * | 2015-03-17 | 2015-05-27 | 邵国辉 | Combination medicine for improving anti-HBV curative effect of interferon and preparation method of combination medicine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
CN1113779A (en) | Anti- hepatitis B preparation | |
CN1245707A (en) | Chinese medicine for curing AIDS and carcinomatosis | |
CN1421234A (en) | Oral liquid for treating hepatitis B | |
CN1067267C (en) | Medicine for treating hepatitis B | |
CN101152539A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
CN1173357A (en) | Pills for treating hepatitis B | |
CN1052413C (en) | Yinhuang Ganfu powder for curing hepatitis | |
CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
CN1052884C (en) | Traditional Chinese medicine Baiyuwan pill for treating vitiligo | |
CN100534506C (en) | Chinese medicinal mixture for treating viral hepatitis | |
CN103948906A (en) | Traditional Chinese medicine preparation for treating hepatitis B and preparation method thereof | |
CN1045387C (en) | "Sancao" medicine powder for hepatitis B | |
CN1562327A (en) | Decoction of turning negative in five steps for virus of hepatitis B | |
CN1098294A (en) | Manganning medicine | |
CN102100775B (en) | Anti-hepatitis-virus medicament composition as well as preparation method and application thereof | |
CN1091963A (en) | Freckle-removing beauty drug | |
CN1923269A (en) | Medicine for treating hepatitis B | |
CN1086141C (en) | Medicine for treating early-stage hepatocirrhosis and its preparation | |
CN1181964A (en) | Hepatitis B transfer-to-negative bolus | |
CN102949658B (en) | Drug formula for treating hepatitis | |
CN116270929A (en) | Pharmaceutical composition for foot bath | |
CN101264296A (en) | Medicaments assembly for treating hepatitis B and preparation thereof | |
CN101062302A (en) | Chinese medicinal preparation for hepatitis B | |
CN1195531C (en) | Chinese medicinal herbs prescription for treating hepatitis B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |